首页> 美国卫生研究院文献>Clinical and Developmental Immunology >Daily Intake of Probiotics with High IFN-γ/IL-10 Ratio Increases the Cytotoxicity of Human Natural Killer Cells: A Personalized Probiotic Approach
【2h】

Daily Intake of Probiotics with High IFN-γ/IL-10 Ratio Increases the Cytotoxicity of Human Natural Killer Cells: A Personalized Probiotic Approach

机译:每天摄入高IFN-γ/ IL-10比例的益生菌会增加人类自然杀伤细胞的细胞毒性:个性化的益生菌方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A personalized probiotic microfluidic chip system has been established and used to screen the probiotics which had the highest value of IFN-γ/IL-10 or IL-10/IFN-γ among six probiotics, including L. paracasei BRAP01, L. acidophilus AD300, B. longum BA100, E. faecium BR0085, L. rhamnosus AD500, and L. reuteri BR101. One hundred volunteers were included and their PBMCs were collected and stimulated by the six probiotics. People who belonged to the IFN-γ group took the probiotics that exerted the highest ratio of IFN-γ/IL-10 and vice versa in IL-10 group. A significant increase in NK cytotoxicity of 69 volunteers in the IFN-γ group was observed compared to the IL-10 group (n = 21) and control group (n = 10). The result also showed that L. paracasei BRAP01 and L. acidophilus AD300 were the two dominant inducers in IFN-γ group which yielded higher value of IFN-γ/IL-10 than the other 4 probiotics, while L. reuteri BR101 was the most effective agent on the ratio of IL-10/IFN-γ in the IL-10 group. Our finding highlighted the concept of personalized probiotics and also provided a good foundation to investigate the probiotics with NK activity.
机译:建立了个性化的益生菌微流控芯片系统,并用于筛选包括副干酪乳杆菌BRAP01,嗜酸乳杆菌AD300在内的6种益生菌中具有最高IFN-γ/ IL-10或IL-10 /IFN-γ值的益生菌。 ,长双歧杆菌BA100,屎肠球菌BR0085,鼠李糖乳杆菌AD500和罗伊氏乳杆菌BR101。包括了一百名志愿者,他们的PBMC被六种益生菌收集和刺激。属于IFN-γ组的人服用的益生菌在IL-10组中占IFN-γ/ IL-10的比例最高,反之亦然。与IL-10组(n = 21)和对照组(n = 10)相比,IFN-γ组的69名志愿者的NK细胞毒性显着增加。结果还表明,副干酪乳杆菌BRAP01和嗜酸乳杆菌AD300是IFN-γ组的两个主要诱导剂,它们产生的IFN- γ / IL-10值高于其他4种益生菌,而L。罗伊氏菌BR101是IL-10组中IL-10 / IFN- γ比例最有效的药物。我们的发现突出了个性化益生菌的概念,也为研究具有NK活性的益生菌提供了良好的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号